Country for PR: Japan
Contributor: Kyodo News JBN
Thursday, April 01 2021 - 19:00
Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists
TOKYO, Apr. 1, 2021 /Kyodo JBN-AsiaNet/ --

Leading Japanese medical VR company Jolly Good Inc. has recently established a 
specialized DTx Division to develop digital therapeutics (hereinafter "DTx") 
using VR and AI technologies.



Dr. Ayako Kanie and Dr. Aiichiro Nakajima, psychiatrists and leaders in the 
development of cognitive behavioral therapy at top research institutes in 
Japan, will officially participate in Jolly Good. The company has been 
developing social skill-training VR for developmental disabilities and digital 
therapeutics VR for depression. After agreeing that Jolly Good's high-quality 
VR could be effective for mental illnesses, both doctors made the decision to 

Issues with Psychotherapy:

In many cases, drug therapy alone is insufficient to treat mental illnesses 
such as depression, and the importance of psychotherapy is gathering more 
attention. However, the issue with conventional psychotherapy is that it is not 
properly delivered to patients who need it, due to the lack of time and 
capability of specialists.

Jolly Good's DTx Division has also applied for an international technology 
patent for providing personalized digital therapeutics by analyzing behavioral 
characteristics and vital data during the VR experience.

Jolly Good is planning business expansion of digital therapeutics globally. 
Negotiations have started with several medical companies about global sales 
partnerships to this end.

Blockbuster TOKYO Business Pitch: A pharmaceutical & medical startup 
acceleration program sponsored by the Tokyo Metropolitan Government


Principal Members:

Photo3: Dr. Ayako Kanie

Senior Medical Supervisor: Ayako Kanie, MD PhD
"The implementation of digital therapeutics using VR will increase treatment 
options for all kinds of people. By engaging with this development from its 
early stages, I hope to expand the potential of VR therapy and prevention."

Specialty: Obsessive-compulsive disorder, anxiety disorder, depression, and 

Photo4: Dr. Aiichiro Nakajima

Medical Supervisor: Aiichiro Nakajima, MD
"Digital therapeutics with VR enables delivery of high-quality treatment in 
short timeframes, delivering treatment to numerous patients in need. I expect 
that it will greatly contribute to the health of patients."

Specialty: Obsessive-compulsive disorder, anxiety disorder, depression, and 

VR DTx official website

About Jolly Good Inc. (
Jolly Good is a medical technology company that develops high-precision VR 
solutions and AI-based medical and welfare services that analyze user behavior 
in the VR space. Using technologies such as VR and AI, the company is 
accelerating human growth and social rehabilitation in medical education, 
support for persons with disabilities, treatment of mental illness, and so on, 
as well as developing services to support the evolution of medical care and 
finding purposes in life, in collaboration with various research institutions 
and companies.

Source: Jolly Good Inc.